Screener
First Tracks Biotherapeutics Inc TRAX Other Income (Expense)
Other Income (Expense) at other companies
Where this comes from
Reported directly by First Tracks Biotherapeutics Inc in its filing.
Tagged under the XBRL concept us-gaap:NonoperatingIncomeExpense.
The source filing: First Tracks Biotherapeutics Inc’s 10-Q, filed May 14, 2026.
- Filed
- May 14, 2026, 4:32 PM EDT
- Fiscal quarter
- Q1 FY2026
- Calendar quarter
- Q1 2026
- Accession
- 0001193125-26-224190
| Line item | Three Months Ended March 31, 2026 | Three Months Ended March 31, 2025 |
|---|---|---|
| Loss from operations | (52,811) | (51,280) |
| Other income (expense), net: | ||
| Interest income | 2,328 | 4,091 |
| Other expense, net | (1) | (7) |
| Total other income, net | 2,327 | 4,084 |
| Net loss | (50,484) | (47,196) |
| Unrealized loss on available-for-sale securities | (122) | (144) |
| Comprehensive loss | $(50,606) | $(47,340) |
Item 1. Combined Financial Statements.
FAQ
- What is First Tracks Biotherapeutics Inc's other income (expense)?
- First Tracks Biotherapeutics Inc (TRAX) reported other income (expense) of $2.33M in Q1 2026.
- What does other income (expense) mean?
- Net total of all non-operating income and expenses not classified in specific line items — a catch-all for miscellaneous financial items.
Ask your AI about First Tracks Biotherapeutics Inc's other income (expense).
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude